Comprehensive analysis of chromosome 8 abnormalities and its prognostic value in patients with uveal melanoma
- Authors: Yarovaya V.A.1, Yarovoy A.A.1, Chudakova L.V.2, Levashov I.A.1, Zaretskiy A.R.2
-
Affiliations:
- S.N. Fedorov MNTC «Eye Microsurgery», Ministry of Health of Russia
- N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
- Issue: Vol 9, No 1 (2022)
- Pages: 57-63
- Section: RESEARCH ARTICLES
- Published: 18.03.2022
- URL: https://umo.abvpress.ru/jour/article/view/417
- DOI: https://doi.org/10.17650/2313-805X-2022-9-1-57-63
- ID: 417
Cite item
Full Text
Abstract
Introduction. Uveal melanoma ability to metastasize depends on a few prognostic factors. The genetic ones are considered to be the most significant. The role of disorders of the short arm of chromosome 8 (8p), as well as a combination of changes in 8p and the long arm of this chromosome (8q) in the development of metastatic lesions in this pathology remains insufficiently studied.
The study objective – to evaluate the prognostic value of chromosome 8 abnormalities in patients with uveal melanoma.
Materials and methods. We analyzed 2 retrospective groups of patients who underwent enucleation for uveal melanoma, statistically homogeneous in the main clinical parameters. Group 1 included patients without signs of metastases (n = 41) with an average follow-up period of 71 months, Group 2 included patients with detected metastases (n = 51) and an average follow-up period of 21 months Chromosome abnormalities were tested by multiplex ligation-dependent probe amplification.
Results. Three- and five-year survival in patients with uveal melanoma without 8p deletion were 64 and 54 %, respectively; with 8p deletion significantly lower – 25 and 6 %, respectively. The same survival rates in patients with uveal melanoma with 8q amplification were 43 and 26 %, respectively, whereas in patients without 8q amplification they were significantly higher – 80 and 74 %, respectively. In patients with uveal melanoma harbouring both abnormalities, 3- and 5-year survival rates were 26 and 7 %, whereas isolated 8q amplification was associated with 47 and 35 % survival, respectively. These survival rates differ greatly and significantly: hazard ratio 3,26 (95 % confidence interval 1,86–5,69) and 6,89 (95 % confidence interval 2,67–17,73), respectively (р <0,0001).
Conclusion. The findings support comprehensive evaluation of chromosome 8 abnormalities as a substantial part of uveal melanoma prognostication. 8q amplification, 8p deletion, combination of these abnormalities and its role in uveal melanoma malignity should be further discovered. Further research in this direction is needed.
About the authors
V. A. Yarovaya
S.N. Fedorov MNTC «Eye Microsurgery», Ministry of Health of Russia
Author for correspondence.
Email: verandreevna@gmail.com
ORCID iD: 0000-0001-8937-7450
Vera Andreevna Yarovaya
59 Beskudnikovsky Bul’var, Moscow127486
Russian FederationA. A. Yarovoy
S.N. Fedorov MNTC «Eye Microsurgery», Ministry of Health of Russia
Email: fake@neicon.ru
ORCID iD: 0000-0003-2219-7054
59 Beskudnikovsky Bul’var, Moscow127486
Russian FederationL. V. Chudakova
N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
Email: fake@neicon.ru
ORCID iD: 0000-0002-8592-1188
1 Ostrovityanova St., Moscow 117997
Russian FederationI. A. Levashov
S.N. Fedorov MNTC «Eye Microsurgery», Ministry of Health of Russia
Email: fake@neicon.ru
ORCID iD: 0000-0001-6949-1002
59 Beskudnikovsky Bul’var, Moscow127486
Russian FederationA. R. Zaretskiy
N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
Email: fake@neicon.ru
ORCID iD: 0000-0002-7778-6617
1 Ostrovityanova St., Moscow 117997
Russian FederationReferences
Supplementary files


